Results 281 to 290 of about 68,610 (290)

The US FDA has granted orphan drug status to Tikvah Therapeutics' sodium phenylbutyrate product,

Inpharma Weekly, 2007
openaire   +1 more source

Flexibility in the FDA approach to orphan drug development

Nature Reviews Drug Discovery, 2017
exaly  

Two decades of orphan product development

Nature Reviews Drug Discovery, 2002
exaly  

FDA approves ultra-orphan drug on a 4-patient trial

Nature Reviews Drug Discovery, 2015
exaly  

Review of: "The orphan drug dichloroacetate reduces amyloid beta-peptide production whilst promoting non-amyloidogenic proteolysis of the amyloid precursor protein"

2021
openaire   +1 more source

Accelerating orphan drug development

Nature Reviews Drug Discovery, 2010
exaly  

The balancing act of orphan drug pricing

Lancet, The, 2017
exaly  

2012 FDA drug approvals

Nature Reviews Drug Discovery, 2013
exaly  

Illuminating orphan GPCRs

Nature Reviews Drug Discovery, 2015
exaly  

HuMax-CD4 [Genmab A/S] has received orphan drug status by the European Agency for the Evaluation of Medicinal Products

Inpharma Weekly, 2004
openaire   +1 more source